Factors affecting virological failure in patients receiving antiretroviral therapy: a prospective HIV Clinical cohort in rural Uganda. Patrick Kazooba1,

Slides:



Advertisements
Similar presentations
Allison Dunning, M.S. Research Biostatistician
Advertisements

High rates of survival, virologic suppression and immune reconstitution among patients receiving second-line ART in the Indian national programme B.B.
Risk factors and true outcomes of children lost to follow-up from antiretroviral therapy in Lilongwe, Malawi C. Ardura Gracia, H. Tweya, C Feldacker, S.
Retention across the continuum of care in a cohort of HIV infected children in rural India G. Alvarez-Uria RDT Hospital, Department of Infectious Diseases,
Patients in routine HIV clinical care at-risk for potentially transmitting HIV in the “test and treat” era of HIV prevention Crane, HM, Mimiaga, M, Feldman,
Validating five questions of antiretroviral non-adherence in a decentralized public-sector antiretroviral treatment program in rural South Africa Krisda.
Uptake of antiretrovirals in a cohort of women involved in high risk sexual behaviour in Kampala, Uganda J.Bukenya, M. Kwikiriza, O. Musana, J. Ssensamba,
Is monitoring for CD4 counts still needed for the management of patients with long- term HIV RNA suppression? Andrew Hill, Liverpool University, UK.
Racial Disparities in Antiretroviral Therapy Use and Viral Suppression among Sexually Active HIV-infected Men who have Sex with Men— United States, Medical.
Washington D.C., USA, JULY Rulin C. Hechter 1 MD,PhD Jean Q. Wang 1 PhD Margo A. Sidell 1 ScD William J. Towner 2 MD 1 Dept.
Increased clinical events in HIV-infected patients who achieve full virologic suppression but fail to attain a CD4 count ≥ 200 cells/mm 3 after one year.
Transition Program of HIV-infected adolescents to Adult HIV care in Buenos Aires, Argentina S. Arazi Caillaud 1, D. Mecikovsky 1, A.Bordato.
Catherine Kober Margaret Johnson Martin Fisher Caroline Sabin On behalf of UK-CHIC BHIVA/BASHH Manchester 2010 Non-uptake of HAART among patients with.
Management and Development for Health (MDH)
Impact of HSV-2 suppressive therapy with daily acyclovir on HIV-1 disease progression: a randomized placebo- controlled trial in Rakai, Uganda Steven J.
Data from the Collaborative HIV Paediatric Study (CHIPS) Reports up to May 2005.
#735 KA Lichtenstein 1, C Armon 2, K Buchacz 3, AC Moorman 3, KC Wood 2, JT Brooks 3, and the HOPS Investigators 1 University of Colorado Health Sciences.
Life expectancy of patients treated with ART in the UK: UK CHIC Study Margaret May University of Bristol, Department of Social Medicine, Bristol.
Neurocognitive Impairment in HIV-Infected Subjects on HAART: Prevalence and Associations Kevin Robertson *1, Kunling Wu 2, Thomas Parsons 1, Ron Ellis.
The Positive Predictive Value of World Health Organization (WHO) Immunologic Criteria for Treatment Failure in a Public Health Antiretroviral Delivery.
Challenges to replacing CD4 testing with viroloigical monitoring Andrew Hill, Pharmacology Research Laboratories, University of Liverpool, UK World AIDS.
Lipoatrophy and lipohypertrophy are independently associated with hypertension: the effect of lipoatrophy but not lipohypertrophy on hypertension is independent.
Community-based Adherence Clubs improve outcomes for stable ART patients: Outcomes from Cape Town, South Africa Anna Grimsrud 1, Maia Lesosky 1,2, Cathy.
Kuala Lumpur, Malaysia, 30 June - 3 July 2013 Outcomes of newly diagnosed HIV- infected patients referred to care after Provider Initiated.
ZIMBABWE AIDS CARE FOUNDATION NEWLANDS CLINIC Virological Outcomes in Adult Patients on Second Line ART, at Newlands Clinic Dr S. Bote.
Good Three-year Outcomes of Antiretroviral Therapy at Multiple NGO- assisted facilities in Four Provinces in South Africa Geoffrey Fatti, Ashraf Grimwood.
The effect of tuberculosis treatment on virologic and immunologic response to combination antiretroviral therapy among South African children Heidi M.
Data from the Collaborative HIV Paediatric Study (CHIPS) Reports up to March 2006* *Numbers are based on reports received rather than children seen to.
INTRODUCTION A previous cohort study from our unit suggested a benefit for the use of efavirenz compared to nevirapine in a group of patients initiating.
Scaling up access to HIV treatment: comparing outcomes among children receiving treatment at mobile and hospital-based HIV clinics in rural Zambia Janneke.
THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS Yield and impact of repeated screening for tuberculosis and isoniazid preventive therapy among patients.
Strategies for Management of Antiretroviral Therapy Study Wafaa El-Sadr and James Neaton for the SMART Study Team.
Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Effect of ART on malaria parasitaemia and clinical episodes in adults in rural Uganda: A population-based cohort study Billy N. Mayanja 1, Kathy Baisley.
Response to Antiretroviral Treatment In an Ethiopian Hospital Samuel Hailemariam, MD, MPH; J Allen McCutchan, MD, MSc Meaza Demissie, MD, PMH, PHD; Alemayehu.
Efavirenz Use Not Associated With Depressive Episodes, According to Analysis of Randomized Clinical Trial Outcomes Slideset on: Journot V, Chene G, De.
Determinants of Family Planning uptake among Female Sex Workers Enrolled in a HIV incidence study in Eldoret Kenya. Authors: J. Kipyego, E. Kaguiri, G.
Successfully enrolled in HIV Care but not linked to timely Treatment: Poor retention and Monitoring of Pre-ART patients who are not yet eligible for ART.
From Aggregate Indicators to Impacting Patients - Data Use to Inform Treatment and Improve Care Ian Wanyeki Track 1.0 Implementers Meeting Dar Es Salaam.
1 Predictors of virological failure in a Cambodian setting Sokkab An, M.D Sihanouk Hospital Center of HOPE (SHCH), Phnom Penh, Cambodia.
Retention in an antiretroviral program in the Democratic Republic of Congo Kalenga Lucien Koole Olivier Menten Joris Kiumbu Modeste Robin Ryder Mukumbi.
Priscilla Tsondai, Lynne Wilkinson, Anna Grimsrud, Angelina Trivino,
Dorina Onoya 1, Cornelius Nattey 1, Eric Budgell 1, Liudmyla van den Berg 2, Denise Evans 1, Mhairi Maskew 1, Kamban Hirasen 1, Lawrence Long 1, Matthew.
1 High levels of risk behavior among people living with HIV initiating and waiting to start antiretroviral therapy in Cape Town South Africa TP Eisele,
Factors associated with loss to follow up in a primary healthcare clinic practicing test and treat Authors: Julius Kiwanuka1,2, Noah Kiwanuka3, Flavia.
PRESENTED AT THE 9TH IAS CONFERENCE ON HIV SCIENCE - PARIS, FRANCE
Earlier treatment and lower mortality in infants Initiating ART at
Viral Suppression at the First Integrated Methadone and Antiretroviral Therapy Program for People who Inject Drugs in sub-Saharan Africa Dar es Salaam,
Title Factors associated with viral suppression among adolescents living with HIV in Cambodia “No conflicts of interest to declare”
Exercise Adherence in Patients with Diabetes: Evaluating the role of psychosocial factors in managing diabetes Natalie N. Young,1, 2 Jennifer P. Friedberg,1,
Conclusions & Implications
L.F. Jefferys1, J. Hector1, M.A. Hobbins2, J. Ehmer2, N. Anderegg3
International AIDS Conference
Validating Definitions of Antiretroviral Treatment Failure in Malawi
Predictors of antiretroviral treatment associated tuberculosis in Ethiopia: a nested case control study Nebiyu Mesfin, MD.
Better Retention Rates Observed in Patients on Lopinavir than Atazanavir in Uganda
MHEALTH to Improve Health: Effectiveness of a weekly text messaging intervention to improve ART adherence and HIV Viral Load: WelTel OAKTREE. M.C.M. Murray1,2,3,
A COLLABORATIVE APPROACH TO ESTABLISH PREDICTORS
San Francisco Department of Public Health
Immunologic and virological response to ART among HIV infected individuals at a tertiary hospital in Ghana ¹Obiri-Yeboah Dorcas, School of Medical Sciences,
Dorina Onoya1, Tembeka Sineke1, Alana Brennan1,2, Matt Fox1,2
24 July 2018 Treatment outcomes with bedaquiline use when substituted for second-line injectables in multidrug resistant tuberculosis: a retrospective.
Long-Term Clinical and Immunologic Outcomes Are Similar in HIV-Infected Persons Randomized to NNRTI versus PI versus NNRTI+PI-based Antiretroviral Regimens.
Management and Development for Health (MDH)
Melissa Herrin, Jan Tate ScD, MPH & Amy Justice, MD, PhD
Andreas D. Haas, PhD Postdoctoral fellow, ICAP at Columbia University
Screening for mental and substance use disorders among adolescents on ART in Southern Africa
Treatment Outcome among patients on ART in Southern Tanzania: Does Time of ART initiation Matter?
Share your thoughts on this presentation with #IAS2019
Public Health Implications
Presentation transcript:

Factors affecting virological failure in patients receiving antiretroviral therapy: a prospective HIV Clinical cohort in rural Uganda. Patrick Kazooba1, Billy Mayanja1, Jonathan Levin1, Ben Masiira1, Nassim Kyakuwa1, Heiner Grosskurth1, 2, Dermot Maher1, Pontiano Kaleebu1, 2 1. MRC/UVRI Uganda Research Unit on AIDS, P.O. Box 49, Entebbe, Uganda 2. London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E, 7HT 3. International Rescue Committee, Tanzania Office, P.O. Box 106048, Dar es Salaam, Tanzania

Background 1 Virological failure is the incomplete viral suppression, or viral rebound after complete suppression while on antiretroviral therapy (ART) for 6 months or more Patients with virological failure require a switch of their ART regimen to a more effective second line ART regimen In resource limited settings, second line ART has cost implications that a pragmatic approach to virological failure is essential before switching to second line ART

Background 2 - several factors are associated with virological failure Justification - several factors are associated with virological failure - a pragmatic approach to virological failure helps avoid unnecessary switching of individuals with conventionally defined virological failure to second line regimen Objectives (a) determine factors affecting virological failure (b) compare pragmatically with conventionally defined virological failure (c) justify the need to use pragmatically defined virological failure to switch patients to second line regimen

Methods Prospective open HIV clinical cohort in rural southwest Uganda ART and contrimoxazole prophylaxis introduced in 2004 All HIV infected participants in the cohort receiving ART were included in the study Between 2004 - 2010 participants were seen quarterly and collected data on: - socio-demographic factors, sexual behavior and ART adherence - medical history and clinical examination - CD4 cell counts measured quarterly -viral load measured 6 monthly

Methods: case definitions Conventional virological failure: a patient with a single viral load greater than 1000 copies/ml or two successive viral load measurements greater than 400 copies/ml, at any time after 6 months on ART Pragmatic virological failures: a patient identified with conventional virological failure, and received intensified adherence counselling and continued on first line ART but still had a viral load of greater than 1000 copies/ml after 6 more months

Methods – statistical analysis For both conventional and pragmatic virological failures: -we calculated failure rates and their 95% CI -examined their explanatory factors separately. Cox proportional hazards regression models were fitted to identify independent predictors of two virological failure definitions Proportion of conventional failures which were also pragmatic failures was calculated for each explanatory variables Logistic regression models were fitted to determine factors associated with being a pragmatic failure among the conventional failures

Results: Baseline characteristics 1 Factor Level N (%) Gender Male Female 115 (36.4%) 201 (63.6%) Age (years) Mean (SD) 37.7 (11.3) Age group (years) 14 – 29 30 – 39 40 – 49 50 + 67 (21.2%) 129 (40.8%) 79 (25.0%) 41 (18.0%) Education Level None or incomplete primary Complete primary or some Secondary Complete secondary or Higher 213 (67.4%) 48 (15.2%) 55 (17.4%) Number of steady partners at enrollment None One Two or More 135 (42.7%) 166 (52.5%) 15 (4.8%) Drink alcohol No Yes 223 (70.6%) 93 (29.4%)

Results: Baseline characteristics 2 Factor Level N (%) Occupation Farmer Trader / Seller Semi-skilled / Skilled Other / missing 192 (60.8%) 42 (13.3%) 18 (5.7%) 64 (20.2%) Weight (kg) Mean (SD) 52.6 (9.5) Weight group (kg) <40 40 - 55 55 - 70 70 + 25 (7.9%) 167 (52.8%) 109 (34.5%) 15 (4.8%) BMI kg /m2 20.1 (2.9) CD4 at ART initiation (cells/µl) Median (IQR) 156 ( 73 – 200) CD4 group at ART initiation (cells/µl) <50 50 – 99 100 – 149 150 – 199 200 + 36 (11.4%) 51 (16.1%) 86 (27.2%) 79 (25.0%)

Results: Baseline characteristics 3 Factor Level N (%) Baseline viral load (copies/ml) Median (IQR) 81,758 (26,721 – 193,814) Baseline viral load group (copies/ml) <400 400 – 999 1000 – 9999 10000 – 99999 100000 – 999999 1000000+ 15 (5.5%) 1 (0.4%) 21 (7.8%) 115 (42.3%) 112 (41.2%) 8 (2.9%) Proportion of visits at which adherence achieved 97 (92 – 100) Adherence achieved in at least 95% of visits No Yes 106 (33.8%) 208 (66.2%)

Summary of conventional virological failure rate broken down by explanatory factors The overall conventional failure rate was 8.6 per 100 pyar, and the rate was: -much higher among participants aged below 30 years -higher among participants who were married or had a steady partner -higher among those who drank alcohol -was almost twice as high among those who reported full adherence at fewer than 95% of visits than amongst those who reported full adherence on 95% or more of visits.

Summary of pragmatic failure rate broken down by explanatory factors Overall the pragmatic failure rate was 2.7 per 100 pyar, and the rate was: - higher among participants aged below 30 years. - higher among those who had one steady partner than for those without a steady partner - higher in those who drank alcohol - was 3 times higher among patients who reported full adherence at fewer than 95% of visits than those who reported full adherence on 95% or more of visits.

Adherence: per 10% decrease in proportion of visits Factors associated with virological failure – Results from fitting Cox models Factor Conventional virological failure ( 84 participants) Pragmatic virological failure (28 Participants) Adjusted HR* (95% CI) P-value Adjusted HR* (95% CI) Aged under 30 years No Yes 1 1.47 (0.90 – 2.39) 0.12 2.83 (1.32 – 6.08) 0.008 Adherence: per 10% decrease in proportion of visits 1.37 (1.22 – 1.55) <0.001 1.42 (1.19 – 1.69) Drinks alcohol 1.38 (0.88 – 2.17) 0.16 2.00 (0.93 – 4.31) 0.076

Proportion of conventional failures who failed pragmatically. 1/3 of the conventional failures also failed pragmatically (28/84). Similar proportions for males and females More than half of the conventional failures aged below 30 also failed pragmatically The proportion failing pragmatically was higher among those who did not achieve adherence on at least 95% of visits Those who drank alcohol were also more likely to fail pragmatically than those who did not drink

Factors associated with Pragmatic Failure among individuals with conventional failure –results from logistic regression Cox models Factor Level Adjusted OR* 95% confidence limits P-value Aged under 30 years No Yes 1 4.67 Reference (1.43 – 15.2) 0.011 Proportion of Adherent visits Per 10% decrease in proportion of visits 1.15 (0.87 – 1.51) <0.001 Drinks alcohol 3.15 (1.01 – 9.81) 0.048

Discussion 1 The pragmatic definition reduced the numbers to be switched to second line ART by 67%, from 84 conventional failures to 28 This supports the conservative approach not to immediately switch patients to second line ART on evidence of conventional virological failure alone Intensified adherence counseling of these patients will keep them on first line ART regimen which is cost effective and safe in resource limited settings and preserve second line ART regimen for as long as possible.

Discussion 2 The finding that lower adherence was associated with failure is not surprising, but in a sense validates our self-reported adherence measurements. The fact that younger patients are at greater risk of failure is important, since some of these may be vertically infected, thus warranting special attention and intensive ART adherence counseling.

Discussion 3 Strengths -Prospective cohort enabled long time regular follow up of participants on ART -Routine laboratory virological assessment of participants on ART enabled assessment of virological failure of treatment Weaknesses -Small numbers of patients in the younger age group did not allow us to explore the age effect more closely -We did not consider other factors e.g. viral subtypes to examine the other factors affecting virological failure

Conclusion In resource limited settings, the pragmatic definition should be used to switch second line ART as this preserves second line ART for longer periods and is also cost effective and safe Using the conventional approach, patients may be incorrectly classified as having treatment failure and unnecessarily switched to second-line therapy. Patient tailored adherence counselling approaches especially for the young patients should be applied to keep them on first line ART regimen for as long as possible.

Acknowledgements Study participants Study clinicians, laboratory and statistics staff for their help and input Medical Research Council (UK) for funding